| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 101.36B | 111.43B | 101.56B | 96.86B | 90.83B | 77.55B |
| Gross Profit | 17.22B | 18.84B | 17.44B | 16.02B | 14.55B | 12.95B |
| EBITDA | 3.52B | 3.76B | 3.97B | 3.47B | 2.65B | 2.42B |
| Net Income | 1.64B | 1.90B | 1.94B | 1.95B | 1.62B | 1.70B |
Balance Sheet | ||||||
| Total Assets | 35.33B | 34.42B | 31.28B | 31.35B | 30.09B | 27.46B |
| Cash, Cash Equivalents and Short-Term Investments | 7.22B | 5.91B | 8.19B | 9.64B | 9.80B | 8.78B |
| Total Debt | 3.81B | 1.04B | 1.53B | 2.07B | 2.52B | 3.01B |
| Total Liabilities | 18.48B | 15.73B | 14.48B | 16.02B | 15.28B | 13.90B |
| Stockholders Equity | 16.56B | 18.38B | 16.50B | 15.06B | 14.57B | 13.56B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.32B | 1.23B | 2.58B | 2.10B | 2.19B |
| Operating Cash Flow | 0.00 | 1.53B | 1.68B | 3.23B | 2.29B | 2.27B |
| Investing Cash Flow | 0.00 | -557.00M | -2.08B | -1.29B | -146.00M | -1.54B |
| Financing Cash Flow | 0.00 | -3.26B | -1.06B | -2.10B | -1.11B | 2.16B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥14.82T | 29.86 | 27.29% | 0.27% | 3.93% | 29.13% | |
69 Neutral | ¥532.63B | 12.37 | 19.18% | 3.59% | 7.21% | 20.34% | |
69 Neutral | ¥107.01B | 14.11 | ― | 7.51% | -14.32% | -17.67% | |
66 Neutral | ¥18.71B | 10.20 | ― | 3.09% | 9.72% | -4.28% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
56 Neutral | ¥53.09B | 10.86 | ― | 3.66% | 25.14% | 5.40% | |
42 Neutral | ¥55.72B | -12.88 | -6.02% | 0.77% | -3.21% | -104.97% |